ResMed reported $2.95 in EPS Earnings Per Share for its fiscal quarter ending in June of 2026.


Fiscal Calendar Actual Consensus Previous Date
FY2026Q1 Sep/2025 2.91 2.86 2.55 Oct/29
FY2026Q4 Jun/2026 2.95 2.89 2.55 Aug/06
FY2026Q3 Mar/2026 2.86 2.82 2.37 Apr/30
FY2026Q2 Dec/2025 2.81 2.7 2.43 Jan/29
FY2026Q1 Sep/2025 2.55 2.52 2.20 Oct/30




Eps Change Date
Ansell USD 0.66 0.5 Dec/2025
Artivion USD -0.02 0.2 Dec/2025
AtriCure USD 0.17 0.01 Sep/2026
Baxter International USD 0.58 0.02 Sep/2026
Cochlear AUD 3.13 0.25 Dec/2025
Cooper Companies USD 2.24 1.2 Jun/2026
CSL USD 5.07 3 Dec/2025
Dexcom USD 0.73 0.03 Sep/2026
Edwards Lifesciences USD 0.8 0.02 Sep/2026
Fisher Paykel Healthcare NZD 0.46 0.08 Jun/2026
Globus Medical USD 1.34 0.22 Jun/2026
Haemonetics USD 1 0.14 Sep/2026
Idexx Laboratories USD 3.96 0.31 Sep/2026
Inogen USD -0.25 0.01 Sep/2024
Insulet USD 1.99 0.33 Sep/2026
Integra LifeSciences USD 0.6 0.04 Sep/2026
Intuitive Surgical USD 2.78 0.02 Sep/2026
Medtronic USD 1.45 0.1 Jun/2026
Philips EUR 0.35 0.14 Sep/2026
Ramsay Health Care AUD 0.7 0.04 Dec/2026
ResMed USD 2.95 0.09 Jun/2026
Sigma Healthcare AUD -0.01 0.01 Dec/2024
Sonic Healthcare AUD 0.7 0.17 Jun/2026
Steris USD 2.44 0.14 Sep/2026
Teleflex USD 2.63 0.87 Sep/2026
Thermo Fisher Scientific USD 5.18 0.86 Sep/2026